Acne vulgaris Trials in New York, United States
Conditions / Acne vulgaris / New York, United States
Clinical trials for Acne vulgaris investigate a range of treatment strategies and patient populations.
41 total trials for this combination
Showing top 10 of 41 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03127956 | A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris | COMPLETED | PHASE3 |
| NCT02566369 | Efficacy and Safety of CD5789 (Trifarotene) 50μg/g Cream Versus Vehicle Cream in Acne Vulgaris | COMPLETED | PHASE3 |
| NCT03271021 | A Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 in the Treatment of Moderate-to-Severe Acne Vulgaris | COMPLETED | PHASE3 |
| NCT00243542 | Phase IV Study to Gather More Information About the Safety of ACZONE Gel, 5% in Treating Subjects With Acne Who Have G6PD Deficiency | COMPLETED | PHASE4 |
| NCT02672332 | P3 Study in Acne Comparing Once Daily SB204 and Vehicle | COMPLETED | PHASE3 |
| NCT02682264 | An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris | COMPLETED | PHASE3 |
| NCT02320149 | Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne | COMPLETED | PHASE3 |
| NCT02667444 | P3 Study Comparing Once Daily SB204 and Vehicle Gel in Acne | COMPLETED | PHASE3 |
| NCT02322866 | Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne | COMPLETED | PHASE3 |
| NCT02413346 | A Multi-Center Open-Label Evaluation of the Safety of Sarecycline Tablets in the Treatment of Acne Vulgaris | COMPLETED | PHASE3 |